Bonk, Inc. (BNKK) AI Stock Analysis

Bonk, Inc. provides over-the-counter and consumer products in the United States. Its primary offering is Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content to support alcohol metabolism and aid recovery. In addition to its functional beverage line, the company provides hair loss treatments, vitiligo solutions, and sexual wellness products. Bonk sells products directly to customers, as well as through distributors, retailers, and e-commerce websites. Formerly known as Safety Shot, Inc., the company rebranded to Bonk, Inc. in October 2025. It was incorporated in 2018, is headquartered in Scottsdale, Arizona, and employs 8 people.

Bonk has experienced significant revenue volatility over the past five fiscal years, posting a 5-year revenue compound annual growth rate of 29.8% from FY2020 to FY2025. Annual revenue dropped to $120,627 in FY2022 before expanding to $202,670 in FY2023, $701,967 in FY2024, and $3.9M in FY2025, which represented 459.8% annual growth. Gross margin improved to positive 31.5% in FY2025 after falling to -348.4% in FY2024. However, net losses widened from -$15.1M in FY2023 and -$49.4M in FY2024 to -$68.2M in FY2025, yielding a net margin of -1735.2%. For the trailing twelve months ended June 30, 2026, revenue stood at $9.3M, supported by latest quarterly year-over-year revenue growth of 2488.3%, while operating margin remained negative at -178.8%.

As of June 30, 2026, Bonk held cash and short-term investments of $290,379 against total debt of $225,042, resulting in net cash of $65,337. Total assets stood at $31.6M and shareholders' equity was $27.5M, supporting a debt-to-equity ratio of 0.01 and a current ratio of 1.05. Ongoing operating cash outflows were -$25.3M in FY2025, yielding free cash flow of -$26.1M after capital expenditures of $834,116. To fund ongoing operations, the company's share count increased 329.4% over a 5-year period.

Bonk trades at a price-to-sales multiple of 1.0x and an enterprise-value-to-revenue ratio of 1.2x, compared to a price-to-sales multiple of 0.7x for the median of its US-listed Consumer Defensive peers. The stock's price-to-book ratio is 0.4x. Over the past year, shares of Bonk fell 87.1%, while the S&P 500 (SPY) returned 16.8%. Over a 5-year horizon, the stock dropped 98.1%, compared to an 83.0% gain for the benchmark index. At its last close of $1.21 on October 16, 2026, the stock traded 45.6% below its 200-day moving average.

The company does not have published analyst consensus ratings, price targets, or earnings estimates on file. Over the trailing twelve months, Bonk recorded diluted earnings per share of -$17.29. Its next earnings announcement is scheduled for November 18, 2026.

This page is an AI-written research summary of Bonk, Inc. (BNKK). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: BNKK income statement, BNKK balance sheet, BNKK key metrics, BNKK chart. See the BNKK stock overview for the latest quote and news.